25 XP   0   0   10

ChemPartner PharmaTech Co Ltd
Buy, Hold or Sell?

Let's analyse ChemPartner PharmaTech Co Ltd together

PenkeI guess you are interested in ChemPartner PharmaTech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ChemPartner PharmaTech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ChemPartner PharmaTech Co Ltd

I send you an email if I find something interesting about ChemPartner PharmaTech Co Ltd.

Quick analysis of ChemPartner PharmaTech Co Ltd (30 sec.)










What can you expect buying and holding a share of ChemPartner PharmaTech Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.77
Expected worth in 1 year
¥7.95
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥3.48
Return On Investment
74.4%

For what price can you sell your share?

Current Price per Share
¥4.67
Expected price per share
¥3.68 - ¥7.06
How sure are you?
50%

1. Valuation of ChemPartner PharmaTech Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.67

Intrinsic Value Per Share

¥-2.13 - ¥0.35

Total Value Per Share

¥2.65 - ¥5.12

2. Growth of ChemPartner PharmaTech Co Ltd (5 min.)




Is ChemPartner PharmaTech Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$329.7m$274.8m$54.8m16.6%

How much money is ChemPartner PharmaTech Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$52.3m-$55.5m$107.9m206.2%
Net Profit Margin28.5%-23.8%--

How much money comes from the company's main activities?

3. Financial Health of ChemPartner PharmaTech Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#166 / 1016

Most Revenue
#76 / 1016

Most Profit
#47 / 1016

Most Efficient
#56 / 1016

What can you expect buying and holding a share of ChemPartner PharmaTech Co Ltd? (5 min.)

Welcome investor! ChemPartner PharmaTech Co Ltd's management wants to use your money to grow the business. In return you get a share of ChemPartner PharmaTech Co Ltd.

What can you expect buying and holding a share of ChemPartner PharmaTech Co Ltd?

First you should know what it really means to hold a share of ChemPartner PharmaTech Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of ChemPartner PharmaTech Co Ltd is ¥4.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ChemPartner PharmaTech Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ChemPartner PharmaTech Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.77. Based on the TTM, the Book Value Change Per Share is ¥0.79 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.93 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ChemPartner PharmaTech Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.102.2%0.102.2%-0.11-2.4%0.020.5%0.020.4%
Usd Book Value Change Per Share0.112.4%0.112.4%-0.13-2.7%0.091.8%0.051.0%
Usd Dividend Per Share0.010.2%0.010.2%0.020.5%0.020.4%0.010.2%
Usd Total Gains Per Share0.122.6%0.122.6%-0.11-2.3%0.102.2%0.061.3%
Usd Price Per Share1.44-1.44-1.91-1.85-1.50-
Price to Earnings Ratio13.74-13.74--17.16-27.46-58.96-
Price-to-Total Gains Ratio11.98-11.98--18.06-14.38-75.62-
Price to Book Ratio2.18-2.18-3.47-2.97-4.50-
Price-to-Total Gains Ratio11.98-11.98--18.06-14.38-75.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.645394
Number of shares1549
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.110.09
Usd Total Gains Per Share0.120.10
Gains per Quarter (1549 shares)186.02158.63
Gains per Year (1549 shares)744.08634.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
164680734103531625
21281360147820610631260
31922040222231015941895
42562720296641321252530
53203400371051626573165
63844080445461931883800
74494760519872237194435
85135440594282642505070
95776120668692947825705
1064168007430103253136340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.01.00.093.8%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.01.00.093.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.01.00.093.8%

Fundamentals of ChemPartner PharmaTech Co Ltd

About ChemPartner PharmaTech Co Ltd

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehensive chemical drug research and development and biological drug services for large and medium-sized pharmaceutical companies, biotechnology companies, and scientific research institutions. The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to Chempartner Pharmatech Co., Ltd. in September 2020. Chempartner Pharmatech Co., Ltd. was founded in 2000 and is headquartered in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 12:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ChemPartner PharmaTech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ChemPartner PharmaTech Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 28.5% means that ¥0.29 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 28.5%. The company is making a huge profit. +2
  • The TTM is 28.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.5%TTM28.5%0.0%
TTM28.5%YOY-23.8%+52.3%
TTM28.5%5Y8.4%+20.2%
5Y8.4%10Y13.7%-5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.5%-199.6%+228.1%
TTM28.5%-213.0%+241.5%
YOY-23.8%-279.3%+255.5%
5Y8.4%-438.4%+446.8%
10Y13.7%-605.5%+619.2%
1.1.2. Return on Assets

Shows how efficient ChemPartner PharmaTech Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • 9.9% Return on Assets means that ChemPartner PharmaTech Co Ltd generated ¥0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 9.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.9%TTM9.9%0.0%
TTM9.9%YOY-9.5%+19.4%
TTM9.9%5Y2.5%+7.4%
5Y2.5%10Y4.5%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9%-13.5%+23.4%
TTM9.9%-12.9%+22.8%
YOY-9.5%-11.8%+2.3%
5Y2.5%-14.1%+16.6%
10Y4.5%-16.0%+20.5%
1.1.3. Return on Equity

Shows how efficient ChemPartner PharmaTech Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • 16.0% Return on Equity means ChemPartner PharmaTech Co Ltd generated ¥0.16 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 16.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.0%TTM16.0%0.0%
TTM16.0%YOY-20.5%+36.5%
TTM16.0%5Y3.1%+13.0%
5Y3.1%10Y5.1%-2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0%-16.9%+32.9%
TTM16.0%-16.1%+32.1%
YOY-20.5%-15.1%-5.4%
5Y3.1%-19.9%+23.0%
10Y5.1%-20.9%+26.0%

1.2. Operating Efficiency of ChemPartner PharmaTech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ChemPartner PharmaTech Co Ltd is operating .

  • Measures how much profit ChemPartner PharmaTech Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of -7.2% means the company generated ¥-0.07  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is -7.2%. The company is operating very inefficient. -2
  • The TTM is -7.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY5.3%-12.5%
TTM-7.2%5Y8.8%-16.0%
5Y8.8%10Y9.9%-1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-295.1%+287.9%
TTM-7.2%-225.8%+218.6%
YOY5.3%-288.4%+293.7%
5Y8.8%-477.4%+486.2%
10Y9.9%-625.6%+635.5%
1.2.2. Operating Ratio

Measures how efficient ChemPartner PharmaTech Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.79 means that the operating costs are ¥1.79 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 1.792. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.792. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.792TTM1.7920.000
TTM1.792YOY1.630+0.162
TTM1.7925Y1.546+0.246
5Y1.54610Y1.173+0.373
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7923.090-1.298
TTM1.7923.264-1.472
YOY1.6303.783-2.153
5Y1.5465.679-4.133
10Y1.1737.894-6.721

1.3. Liquidity of ChemPartner PharmaTech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ChemPartner PharmaTech Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.75 means the company has ¥1.75 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 1.749. The company is able to pay all its short-term debts. +1
  • The TTM is 1.749. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.749TTM1.7490.000
TTM1.749YOY0.694+1.055
TTM1.7495Y1.340+0.409
5Y1.34010Y5.071-3.731
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7493.914-2.165
TTM1.7494.220-2.471
YOY0.6945.388-4.694
5Y1.3406.045-4.705
10Y5.0716.406-1.335
1.3.2. Quick Ratio

Measures if ChemPartner PharmaTech Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.47 means the company can pay off ¥0.47 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 0.467. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.467. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.467TTM0.4670.000
TTM0.467YOY0.404+0.063
TTM0.4675Y0.597-0.130
5Y0.59710Y4.337-3.740
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4673.572-3.105
TTM0.4673.998-3.531
YOY0.4045.390-4.986
5Y0.5975.969-5.372
10Y4.3376.287-1.950

1.4. Solvency of ChemPartner PharmaTech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ChemPartner PharmaTech Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ChemPartner PharmaTech Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.38 means that ChemPartner PharmaTech Co Ltd assets are financed with 37.6% credit (debt) and the remaining percentage (100% - 37.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 0.376. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.376. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.376TTM0.3760.000
TTM0.376YOY0.528-0.152
TTM0.3765Y0.408-0.032
5Y0.40810Y0.242+0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3760.336+0.040
TTM0.3760.334+0.042
YOY0.5280.269+0.259
5Y0.4080.366+0.042
10Y0.2420.390-0.148
1.4.2. Debt to Equity Ratio

Measures if ChemPartner PharmaTech Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 60.9% means that company has ¥0.61 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The MRQ is 0.609. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.609. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.609TTM0.6090.000
TTM0.609YOY1.134-0.526
TTM0.6095Y0.718-0.109
5Y0.71810Y0.404+0.314
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6090.382+0.227
TTM0.6090.396+0.213
YOY1.1340.335+0.799
5Y0.7180.434+0.284
10Y0.4040.465-0.061

2. Market Valuation of ChemPartner PharmaTech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings ChemPartner PharmaTech Co Ltd generates.

  • Above 15 is considered overpriced but always compare ChemPartner PharmaTech Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 13.74 means the investor is paying ¥13.74 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The EOD is 6.165. Based on the earnings, the company is cheap. +2
  • The MRQ is 13.742. Based on the earnings, the company is underpriced. +1
  • The TTM is 13.742. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.165MRQ13.742-7.577
MRQ13.742TTM13.7420.000
TTM13.742YOY-17.158+30.901
TTM13.7425Y27.463-13.720
5Y27.46310Y58.959-31.496
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.165-2.259+8.424
MRQ13.742-2.569+16.311
TTM13.742-2.664+16.406
YOY-17.158-4.120-13.038
5Y27.463-6.258+33.721
10Y58.959-6.171+65.130
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The EOD is -31.652. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -70.555. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -70.555. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-31.652MRQ-70.555+38.904
MRQ-70.555TTM-70.5550.000
TTM-70.555YOY74.842-145.398
TTM-70.5555Y-50.962-19.594
5Y-50.96210Y-85.398+34.436
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-31.652-2.924-28.728
MRQ-70.555-3.246-67.309
TTM-70.555-3.488-67.067
YOY74.842-5.620+80.462
5Y-50.962-8.315-42.647
10Y-85.398-8.826-76.572
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ChemPartner PharmaTech Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.18 means the investor is paying ¥2.18 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of ChemPartner PharmaTech Co Ltd:

  • The EOD is 0.978. Based on the equity, the company is cheap. +2
  • The MRQ is 2.181. Based on the equity, the company is underpriced. +1
  • The TTM is 2.181. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.978MRQ2.181-1.202
MRQ2.181TTM2.1810.000
TTM2.181YOY3.470-1.289
TTM2.1815Y2.969-0.789
5Y2.96910Y4.498-1.528
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9781.851-0.873
MRQ2.1812.090+0.091
TTM2.1812.095+0.086
YOY3.4702.844+0.626
5Y2.9693.466-0.497
10Y4.4983.815+0.683
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ChemPartner PharmaTech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7940.7940%-0.927+217%0.620+28%0.349+127%
Book Value Per Share--4.7744.7740%3.980+20%4.536+5%3.008+59%
Current Ratio--1.7491.7490%0.694+152%1.340+31%5.071-66%
Debt To Asset Ratio--0.3760.3760%0.528-29%0.408-8%0.242+55%
Debt To Equity Ratio--0.6090.6090%1.134-46%0.718-15%0.404+51%
Dividend Per Share--0.0750.0750%0.162-54%0.121-38%0.076-1%
Eps--0.7580.7580%-0.805+206%0.172+339%0.139+446%
Free Cash Flow Per Share---0.148-0.1480%0.185-180%0.025-697%0.045-431%
Free Cash Flow To Equity Per Share---1.869-1.8690%-0.334-82%-0.121-94%0.005-37968%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.345--------
Intrinsic Value_10Y_min---2.126--------
Intrinsic Value_1Y_max--0.043--------
Intrinsic Value_1Y_min---0.071--------
Intrinsic Value_3Y_max--0.122--------
Intrinsic Value_3Y_min---0.337--------
Intrinsic Value_5Y_max--0.194--------
Intrinsic Value_5Y_min---0.737--------
Market Cap2333958552.640-123%5202678486.7205202678486.7200%6901920259.520-25%6681018829.056-22%5438568229.174-4%
Net Profit Margin--0.2850.2850%-0.238+183%0.084+241%0.137+109%
Operating Margin---0.072-0.0720%0.053-236%0.088-182%0.099-173%
Operating Ratio--1.7921.7920%1.630+10%1.546+16%1.173+53%
Pb Ratio0.978-123%2.1812.1810%3.470-37%2.969-27%4.498-52%
Pe Ratio6.165-123%13.74213.7420%-17.158+225%27.463-50%58.959-77%
Price Per Share4.670-123%10.41010.4100%13.810-25%13.368-22%10.882-4%
Price To Free Cash Flow Ratio-31.652+55%-70.555-70.5550%74.842-194%-50.962-28%-85.398+21%
Price To Total Gains Ratio5.374-123%11.98011.9800%-18.060+251%14.382-17%75.618-84%
Quick Ratio--0.4670.4670%0.404+16%0.597-22%4.337-89%
Return On Assets--0.0990.0990%-0.095+196%0.025+293%0.045+118%
Return On Equity--0.1600.1600%-0.205+228%0.031+423%0.051+213%
Total Gains Per Share--0.8690.8690%-0.765+188%0.741+17%0.425+105%
Usd Book Value--329739852.634329739852.6340%274890425.723+20%313306982.691+5%207732245.986+59%
Usd Book Value Change Per Share--0.1100.1100%-0.128+217%0.086+28%0.048+127%
Usd Book Value Per Share--0.6600.6600%0.550+20%0.627+5%0.416+59%
Usd Dividend Per Share--0.0100.0100%0.022-54%0.017-38%0.010-1%
Usd Eps--0.1050.1050%-0.111+206%0.024+339%0.019+446%
Usd Free Cash Flow---10190718.792-10190718.7920%12744718.262-180%1706819.180-697%3081592.853-431%
Usd Free Cash Flow Per Share---0.020-0.0200%0.026-180%0.003-697%0.006-431%
Usd Free Cash Flow To Equity Per Share---0.258-0.2580%-0.046-82%-0.017-94%0.001-37968%
Usd Market Cap322553071.975-123%719010166.865719010166.8650%953845379.866-25%923316802.176-22%751610129.272-4%
Usd Price Per Share0.645-123%1.4391.4390%1.909-25%1.847-22%1.504-4%
Usd Profit--52320447.96352320447.9630%-55590269.335+206%11909798.337+339%9585255.036+446%
Usd Revenue--183333953.041183333953.0410%233651691.768-22%188604180.671-3%113440664.352+62%
Usd Total Gains Per Share--0.1200.1200%-0.106+188%0.102+17%0.059+105%
 EOD+3 -5MRQTTM+0 -0YOY+21 -145Y+20 -1510Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of ChemPartner PharmaTech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.165
Price to Book Ratio (EOD)Between0-10.978
Net Profit Margin (MRQ)Greater than00.285
Operating Margin (MRQ)Greater than0-0.072
Quick Ratio (MRQ)Greater than10.467
Current Ratio (MRQ)Greater than11.749
Debt to Asset Ratio (MRQ)Less than10.376
Debt to Equity Ratio (MRQ)Less than10.609
Return on Equity (MRQ)Greater than0.150.160
Return on Assets (MRQ)Greater than0.050.099
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of ChemPartner PharmaTech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.894
Ma 20Greater thanMa 505.388
Ma 50Greater thanMa 1005.307
Ma 100Greater thanMa 2006.478
OpenGreater thanClose4.660
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
EBIT  184,044-321183,72317,890201,612-111,97489,638-185,200-95,562
Operating Income  195,08313,223208,3067,028215,334-125,69689,638-151,115-61,476



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,823,897
Total Liabilities1,437,936
Total Stockholder Equity2,361,536
 As reported
Total Liabilities 1,437,936
Total Stockholder Equity+ 2,361,536
Total Assets = 3,823,897

Assets

Total Assets3,823,897
Total Current Assets1,280,359
Long-term Assets2,543,538
Total Current Assets
Cash And Cash Equivalents 761,664
Net Receivables 341,495
Inventory 42,817
Other Current Assets 38,822
Total Current Assets  (as reported)1,280,359
Total Current Assets  (calculated)1,184,798
+/- 95,562
Long-term Assets
Property Plant Equipment 973,617
Goodwill 858,860
Intangible Assets 55,656
Other Assets 458,386
Long-term Assets  (as reported)2,543,538
Long-term Assets  (calculated)2,346,520
+/- 197,018

Liabilities & Shareholders' Equity

Total Current Liabilities732,031
Long-term Liabilities705,905
Total Stockholder Equity2,361,536
Total Current Liabilities
Short Long Term Debt 115,023
Accounts payable 80,698
Other Current Liabilities 257,014
Total Current Liabilities  (as reported)732,031
Total Current Liabilities  (calculated)452,734
+/- 279,297
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt495,253
Long-term Liabilities Other 5,024
Deferred Long Term Liability 370,233
Long-term Liabilities  (as reported)705,905
Long-term Liabilities  (calculated)870,511
+/- 164,606
Total Stockholder Equity
Common Stock499,777
Retained Earnings 648,265
Other Stockholders Equity 9,813
Total Stockholder Equity (as reported)2,361,536
Total Stockholder Equity (calculated)1,157,855
+/- 1,203,681
Other
Capital Stock499,777
Common Stock Shares Outstanding 499,777
Net Invested Capital 2,653,769
Net Tangible Assets 1,447,020
Net Working Capital 548,328
Property Plant and Equipment Gross 973,617



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
67,787
86,933
136,300
587,421
633,821
667,614
703,988
741,128
756,004
793,164
1,043,177
3,347,701
3,767,717
4,121,581
4,217,592
3,823,897
3,823,8974,217,5924,121,5813,767,7173,347,7011,043,177793,164756,004741,128703,988667,614633,821587,421136,30086,93367,787
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
514,505
507,340
735,316
800,187
919,879
687,745
1,280,359
1,280,359687,745919,879800,187735,316507,340514,505000000000
       Cash And Cash Equivalents 
22,622
18,713
28,722
454,744
434,387
358,159
292,508
271,736
50,072
112,050
291,497
190,803
201,050
259,121
160,460
761,664
761,664160,460259,121201,050190,803291,497112,05050,072271,736292,508358,159434,387454,74428,72218,71322,622
       Short-term Investments 
0
0
0
0
0
0
0
38,000
328,000
313,000
124,339
0
64,400
20,075
18,983
0
018,98320,07564,4000124,339313,000328,00038,0000000000
       Net Receivables 
7,994
9,835
17,677
42,578
50,984
43,100
53,447
60,247
45,021
49,387
57,740
352,887
413,633
384,471
380,772
341,495
341,495380,772384,471413,633352,88757,74049,38745,02160,24753,44743,10050,98442,57817,6779,8357,994
       Other Current Assets 
7,199
15,886
14,297
9,373
16,607
9,068
46,643
13,961
15,684
17,470
8,983
51,312
53,226
76,464
58,718
38,822
38,82258,71876,46453,22651,3128,98317,47015,68413,96146,6439,06816,6079,37314,29715,8867,199
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
278,659
535,837
2,612,385
2,967,530
3,201,702
3,529,847
2,543,538
2,543,5383,529,8473,201,7022,967,5302,612,385535,837278,659000000000
       Property Plant Equipment 
16,852
28,295
53,024
62,025
77,630
154,207
214,270
231,333
160,602
152,063
156,782
564,460
648,192
946,131
1,511,519
973,617
973,6171,511,519946,131648,192564,460156,782152,063160,602231,333214,270154,20777,63062,02553,02428,29516,852
       Goodwill 
0
0
0
0
0
0
0
4,583
0
0
0
1,617,059
1,617,059
1,575,059
1,207,459
858,860
858,8601,207,4591,575,0591,617,0591,617,0590004,5830000000
       Intangible Assets 
3,249
4,186
5,691
2,779
3,297
3,973
939
52,551
46,904
45,074
43,244
212,263
192,491
165,001
148,610
55,656
55,656148,610165,001192,491212,26343,24445,07446,90452,5519393,9733,2972,7795,6914,1863,249
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
382
1,217
52,850
78,415
13,802
46,528
61,009
61,00946,52813,80278,41552,8501,217382000000000
> Total Liabilities 
43,534
28,575
35,040
16,120
22,366
26,716
33,698
44,602
32,194
23,234
207,731
1,143,195
1,464,374
1,669,193
2,228,515
1,437,936
1,437,9362,228,5151,669,1931,464,3741,143,195207,73123,23432,19444,60233,69826,71622,36616,12035,04028,57543,534
   > Total Current Liabilities 
24,365
27,647
31,410
15,120
21,116
25,916
33,221
44,025
30,216
21,135
25,801
354,551
789,243
787,600
990,657
732,031
732,031990,657787,600789,243354,55125,80121,13530,21644,02533,22125,91621,11615,12031,41027,64724,365
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
49,800
93,400
0
0
0
00093,40049,80000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
49,800
93,400
112,500
158,566
115,023
115,023158,566112,50093,40049,80000000000000
       Accounts payable 
5,934
4,661
10,748
9,468
10,558
10,210
19,647
27,190
12,527
5,353
6,677
69,977
90,958
80,167
108,378
80,698
80,698108,37880,16790,95869,9776,6775,35312,52727,19019,64710,21010,5589,46810,7484,6615,934
       Other Current Liabilities 
12,431
9,236
5,662
5,652
10,558
12,706
13,574
16,835
17,689
4,050
8,384
100,556
413,139
251,424
261,280
257,014
257,014261,280251,424413,139100,5568,3844,05017,68916,83513,57412,70610,5585,6525,6629,23612,431
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
2,099
181,930
788,645
675,130
881,593
1,237,857
705,905
705,9051,237,857881,593675,130788,645181,9302,099000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
-49,800
-93,400
0
570,576
495,253
495,253570,5760-93,400-49,80000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
1,000
181,000
181,000
27,969
30,621
5,815
5,024
5,0245,81530,62127,969181,000181,0001,000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
222
268
59,168
260,213
281,790
385,022
370,233
370,233385,022281,790260,21359,168268222000000000
> Total Stockholder Equity
24,053
58,153
101,260
571,300
589,757
616,996
646,594
675,231
723,737
769,865
811,579
2,190,031
2,291,889
2,427,904
1,964,445
2,361,536
2,361,5361,964,4452,427,9042,291,8892,190,031811,579769,865723,737675,231646,594616,996589,757571,300101,26058,15324,053
   Common Stock
6,000
38,000
50,000
67,000
134,000
201,000
201,000
301,500
422,100
422,100
422,100
499,777
499,777
499,777
499,777
499,777
499,777499,777499,777499,777499,777422,100422,100422,100301,500201,000201,000134,00067,00050,00038,0006,000
   Retained Earnings 
16,094
17,084
39,123
63,619
79,386
103,034
128,453
176,238
223,648
267,524
304,228
448,421
552,359
706,910
269,680
648,265
648,265269,680706,910552,359448,421304,228267,524223,648176,238128,453103,03479,38663,61939,12317,08416,094
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
7,006
8,674
-7,970
-13,757
9,813
9,813-13,757-7,9708,6747,00600000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,140,525
Cost of Revenue-974,760
Gross Profit165,766165,766
 
Operating Income (+$)
Gross Profit165,766
Operating Expense-1,260,507
Operating Income-119,981-1,094,741
 
Operating Expense (+$)
Research Development70,853
Selling General Administrative53,626
Selling And Marketing Expenses-
Operating Expense1,260,507124,480
 
Net Interest Income (+$)
Interest Income6,531
Interest Expense-45,469
Other Finance Cost-41,608
Net Interest Income-80,546
 
Pretax Income (+$)
Operating Income-119,981
Net Interest Income-80,546
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-687,814-119,981
EBIT - interestExpense = -45,469
-686,011
-640,541
Interest Expense45,469
Earnings Before Interest and Taxes (EBIT)--642,345
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-687,814
Tax Provision--1,615
Net Income From Continuing Ops-686,199-686,199
Net Income-686,011
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-80,546
 

Technical Analysis of ChemPartner PharmaTech Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ChemPartner PharmaTech Co Ltd. The general trend of ChemPartner PharmaTech Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ChemPartner PharmaTech Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChemPartner PharmaTech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.07 < 6.7 < 7.06.

The bearish price targets are: 3.68.

Tweet this
ChemPartner PharmaTech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChemPartner PharmaTech Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChemPartner PharmaTech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChemPartner PharmaTech Co Ltd. The current macd is -0.26442125.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ChemPartner PharmaTech Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ChemPartner PharmaTech Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ChemPartner PharmaTech Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ChemPartner PharmaTech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChemPartner PharmaTech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChemPartner PharmaTech Co Ltd. The current adx is 25.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ChemPartner PharmaTech Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ChemPartner PharmaTech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChemPartner PharmaTech Co Ltd. The current sar is 5.2031527.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ChemPartner PharmaTech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChemPartner PharmaTech Co Ltd. The current rsi is 37.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
ChemPartner PharmaTech Co Ltd Daily Relative Strength Index (RSI) ChartChemPartner PharmaTech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChemPartner PharmaTech Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ChemPartner PharmaTech Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ChemPartner PharmaTech Co Ltd Daily Stochastic Oscillator ChartChemPartner PharmaTech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChemPartner PharmaTech Co Ltd. The current cci is -135.36117317.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ChemPartner PharmaTech Co Ltd Daily Commodity Channel Index (CCI) ChartChemPartner PharmaTech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChemPartner PharmaTech Co Ltd. The current cmo is -29.47926696.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ChemPartner PharmaTech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartChemPartner PharmaTech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChemPartner PharmaTech Co Ltd. The current willr is -69.49152542.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ChemPartner PharmaTech Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ChemPartner PharmaTech Co Ltd Daily Williams %R ChartChemPartner PharmaTech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChemPartner PharmaTech Co Ltd.

ChemPartner PharmaTech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChemPartner PharmaTech Co Ltd. The current atr is 0.33713166.

ChemPartner PharmaTech Co Ltd Daily Average True Range (ATR) ChartChemPartner PharmaTech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChemPartner PharmaTech Co Ltd. The current obv is -42,149,152.

ChemPartner PharmaTech Co Ltd Daily On-Balance Volume (OBV) ChartChemPartner PharmaTech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChemPartner PharmaTech Co Ltd. The current mfi is 42.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ChemPartner PharmaTech Co Ltd Daily Money Flow Index (MFI) ChartChemPartner PharmaTech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChemPartner PharmaTech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

ChemPartner PharmaTech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChemPartner PharmaTech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.894
Ma 20Greater thanMa 505.388
Ma 50Greater thanMa 1005.307
Ma 100Greater thanMa 2006.478
OpenGreater thanClose4.660
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ChemPartner PharmaTech Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on ChemPartner PharmaTech Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ChemPartner PharmaTech Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChemPartner PharmaTech Co Ltd

I send you an email if I find something interesting about ChemPartner PharmaTech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ChemPartner PharmaTech Co Ltd.

Receive notifications about ChemPartner PharmaTech Co Ltd in your mailbox!